Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Introduction of a new model for time-continuous and non-contact investigations of in-vitro thrombolysis under physiological flow conditions

 
: Roessler, F.C.; Ohlrich, M.; Marxsen, J.H.; Schmieger, M.; Weber, P.-K.; Stellmacher, F.; Trillenberg, P.; Eggers, J.; Seidel, G.

:
Postprint (2.8 MByte; PDF; )

BMC neurology. Online journal 11 (2011), Art. 58
http://www.biomedcentral.com/1471-2377/
ISSN: 1471-2377
Englisch
Zeitschriftenaufsatz, Elektronische Publikation
Fraunhofer IBMT ()

Abstract
Background: Thrombolysis is a dynamic and time-dependent process influenced by the haemodynamic conditions. Currently there is no model that allows for time-continuous, non-contact measurements under physiological flow conditions. The aim of this work was to introduce such a model.
Methods: The model is based on a computer-controlled pump providing variable constant or pulsatile flows in a tube system filled with blood substitute. Clots can be fixed in a custom-built clot carrier within the tube system. The pressure decline at the clot carrier is measured as a novel way to measure lysis of the clot. With different experiments the hydrodynamic properties and reliability of the model were analyzed. Finally, the lysis rate of clots generated from human platelet rich plasma (PRP) was measured during a one hour combined application of diagnostic ultrasound (2 MHz, 0.179 W/cm2) and a thrombolytic agent (rt-PA) as it is commonly used for clinical sonothrombolysis treatments.
Results: All hydrodynamic parameters can be adjusted and measured with high accuracy. First experiments with sonothrombolysis demonstrated the feasibility of the model despite low lysis rates.
Conclusions: The model allows to adjust accurately all hydrodynamic parameters affecting thrombolysis under physiological flow conditions and for non-contact, time-continuous measurements. Low lysis rates of first sonothrombolysis experiments are primarily attributable to the high stability of the used PRP-clots.

: http://publica.fraunhofer.de/dokumente/N-189877.html